# Intramuscular Ketamine for Suicidal Ideation

> **NCT05105061** · PHASE2 · WITHDRAWN · sponsor: **Icahn School of Medicine at Mount Sinai**

## Conditions studied

- Suicidal Ideation

## Interventions

- **DRUG:** Ketamine (Ketalar)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05105061
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02
- **Primary completion:** 2022-03-24
- **Final completion:** 2022-03-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI leaving institution
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05105061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05105061, "Intramuscular Ketamine for Suicidal Ideation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05105061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*